Elicio Therapeutics Competitors and Similar CompaniesClear all

Elicio Therapeutics's competitors and similar companies include Arvinas, Core Biogenesis and NextCure.

	Elicio Therapeutics Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers.	Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.	Core Biogenesis Core Biogenesis is a biotech company developing a production platform to express recombinant proteins from plants.	NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.
Founding Date	Founding Date 2011	Founding Date N/A	Founding Date 2020	Founding Date 2015
Type	Type Public	Type Public	Type Private	Type Public
Tags	Tags Technology drug development oncology pharma therapy	Tags Healthcare Technology drug development oncology pharma platform therapy	Tags Technology biotech drug development oncology pharma therapy	Tags Healthcare Technology biotech drug development oncology pharma platform therapy
Locations	Locations Cambridge, US HQ	Locations New Haven, US HQ	Locations Paris, FR HQ Illkirch Graffenstaden, FR	Locations Beltsville, US HQ
Employees	Employees 22	Employees 13329% increase	Employees 293% decrease	Employees N/A
Valuation ($)	Valuation ($) 47.5 m	Valuation ($) 1.9 b	Valuation ($) N/A	Valuation ($) 39.2 m
Financial
Net income	Net income ($39.6m) (FY, 2025)	Net income ($80.8m) (FY, 2025)	Net income N/A	Net income ($55.8m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 150.3m	Total funding raised $ 111.6m	Total funding raised $ 14.1m	Total funding raised $ 160m